Johnson & Johnson’s vaccine offers strong protection but fuels concern about variants

The vaccine’s efficacy rate is 72% in the United States and 57% in South Africa, where a highly contagious variant is driving most cases.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2MiktSL
via IFTTT